Cover Image
Market Research Report

Nebulizer Market Size, Share & Trends Analysis Report By Type (Jet, Mesh, Ultrasonic), By End-use (Hospitals & Clinics, Emergency Centers & Home Healthcare), And Segment Forecasts, 2019 - 2026

Published by Grand View Research, Inc. Product code 615517
Published Content info 110 Pages
Delivery time: 2-3 business days
Price
Back to Top
Nebulizer Market Size, Share & Trends Analysis Report By Type (Jet, Mesh, Ultrasonic), By End-use (Hospitals & Clinics, Emergency Centers & Home Healthcare), And Segment Forecasts, 2019 - 2026
Published: August 13, 2019 Content info: 110 Pages
Description

The global nebulizer market size is expected to reach USD 1.4 billion by 2026, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.5% over the forecast period. Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to the market growth.

According to the Population Reference Bureau report, "Aging in the United States", the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

On the other hand, drug loss during nebulization is the major factor restraining the market growth. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss. Furthermore, increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth.

Technological advancements such as drug-device combination is further expected to create newer opportunity in the nebulizer market. The key manufacturers are expected to dominate the market of drug device combinations till the generic mesh nebulizer manufacturers invest in the support infrastructure required for development of the new pharmaceuticals. For instance; In 2016, Sunovion filed the first application for the approval of SUN-101. A mesh nebulizer in combination with a drug for COPD (SUN-101) will be a significant step for boosting the adoption of nebulizers. Other companies such as Vectura also have products in late stage development, e.g., VR475, indicated for severe asthma, in Phase III trials.

Further Key Findings from the Study Suggest:

  • Jet nebulizer held over 60.0% market share in 2018 owing to the greater penetration and low cost of the devices
  • Mesh nebulizers is the fastest growing segment with the CAGR of 7.7% due to various benefits including portability, convenience, homecare application and accurate dosage delivery
  • According to the Population Reference Bureau report, "Aging in the United States", the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060.
  • The demand is expected to increase in homecare application. Easy availability of compact nebulizers that are ideal for home use and technological innovations in nebulizers to reduce the sound created by them and to improve their functionality are increasing their adoption in home healthcare.
  • North America dominated the regional nebulizer market segment in 2018. This high share can be attributed to increase in incidence of respiratory diseases, supportive government policies, favorable reimbursement schemes, rise in awareness, and increase use of home care products
  • As per the analysis of the U.S. and EU clinical trial databases, 2017, mesh nebulizers are more preferred for clinical trials sponsored by pharmaceutical companies over jet nebulizers.

Key players include: Omron Corporation, Koninklijke Philips N.V., PARI Pharma, Allied Healthcare Products, Inc., Becton Dickinson and Company, Agilent Technologies, Medline Industries, Briggs Healthcare, Drive Medical and GF Health Products, Inc.

Table of Contents
Product Code: GVR-2-68038-069-9

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Type
    • 1.1.2 End use
    • 1.1.3 regional scope
    • 1.1.4 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
      • 1.3.5.1 Data for primary interviews in North america
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Middle East and Africa
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume price analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume price analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Nebulizer Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Rising incidence of chronic respiratory diseases
      • 3.3.1.2 Increasing demand for home healthcare devices
      • 3.3.1.3 Rising geriatric population base
    • 3.3.2 Market restrain analysis
      • 3.3.2.1 Drug loss during drug delivery
  • 3.4 Nebulizer: Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
    • 3.4.2 PESTLE analysis
    • 3.4.3 Respiratory Disease Prevalence
    • 3.4.4 Opportunity Analysis
    • 3.4.5 Technology Timeline and trend analysis

Chapter 4 Nebulizer Market: Segment Analysis, By Type, 2014 - 2026 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Type Market Share Analysis, 2018 & 2026
  • 4.3 Segment Dashboard
  • 4.4 Global Nebulizer Market, by Type, 2014 to 2026
  • 4.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026
    • 4.5.1 Jet nebulizer
      • 4.5.1.1 Jet nebulizer market, 2014 - 2026 (USD Million)
    • 4.5.2 Mesh nebulizer
      • 4.5.2.1 Mesh nebulizer market, 2014 - 2026 (USD Million)
    • 4.5.3 Ultrasonic nebulizer
      • 4.5.3.1 Ultrasonic nebulizer market, 2014 - 2026 (USD Million)

Chapter 5 Nebulizer Market: Segment Analysis, By End Use, 2014 - 2026 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 End Use Market Share Analysis, 2018 & 2026
  • 5.3 Segment Dashboard
  • 5.4 Global Nebulizer Market, by End Use, 2014 to 2026
  • 5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026
    • 5.5.1 Hospitals and Clinics
      • 5.5.1.1 Hospitals and Clinics market, 2014 - 2026 (USD Million)
    • 5.5.2 Emergency Centers
      • 5.5.2.1 Emergency Centers market, 2014 - 2026 (USD Million)
    • 5.5.3 Home Healthcare
      • 5.5.3.1 Home Healthcare market, 2014 - 2026 (USD Million)

Chapter 6 Nebulizer Market: Regional Market Analysis, By Type and End Use, 2014 - 2026 (USD Million)

  • 6.1 Definition & Scope
  • 6.2 Regional Market Share Analysis, 2018 & 2026
  • 6.3 Regional Market Dashboard
  • 6.4 Global Nebulizer Market, by Regions, 2014 to 2026
  • 6.5 Regional Market Snapshot
  • 6.6 Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2025
  • 6.7 North America
    • 6.7.1 North America Market estimates and forecast, by country, 2015-2026 (USD Million)
    • 6.7.2 North America Nebulizer market, by type, 2014 - 2026 (USD Million)
    • 6.7.3 North America Nebulizer market, by end use, 2014 - 2026 (USD Million)
    • 6.7.4 U.S.
      • 6.7.4.1 U.S. Nebulizer market, 2014 - 2026 (USD Million)
    • 6.7.5 Canada
      • 6.7.5.1 Canada Nebulizer market, 2014 - 2026 (USD Million)
  • 6.8 Europe
    • 6.8.1 Europe Nebulizer market, by country, 2014 - 2026 (USD Million)
    • 6.8.2 Europe Nebulizer market, by type, 2014 - 2026 (USD Million)
    • 6.8.3 Europe Nebulizer market, by end use, 2014 - 2026 (USD Million)
    • 6.8.4 UK
      • 6.8.4.1 UK Nebulizer market, 2014 - 2026 (USD Million)
    • 6.8.5 Germany
      • 6.8.5.1 Germany Nebulizer market, 2014 - 2026 (USD Million)
    • 6.8.6 France
      • 6.8.6.1 France Nebulizer market, 2014 - 2026 (USD Million)
    • 6.8.7 Italy
      • 6.8.7.1 Italy Nebulizer market, 2014 - 2026 (USD Million)
    • 6.8.8 Spain
      • 6.8.8.1 Spain Nebulizer market, 2014 - 2026 (USD Million)
    • 6.8.9 Russia
      • 6.8.9.1 Russia Nebulizer market, 2014 - 2026 (USD Million)
  • 6.9 Asia Pacific
    • 6.9.1 Asia Pacific Nebulizer market, by country, 2014 - 2026 (USD Million)
    • 6.9.2 Asia Pacific Nebulizer market, by type, 2014 - 2026 (USD Million)
    • 6.9.3 Asia Pacific Nebulizer market, by end use, 2014 - 2026 (USD Million)
    • 6.9.4 Japan
      • 6.9.4.1 Japan Nebulizer market, 2014 - 2026 (USD Million)
    • 6.9.5 China
      • 6.9.5.1 China Nebulizer market, 2014 - 2026 (USD Million)
    • 6.9.6 India
      • 6.9.6.1 India Nebulizer market, 2014 - 2026 (USD Million)
    • 6.9.7 Malaysia
      • 6.9.7.1 malaysia Nebulizer market, 2014 - 2026 (USD Million)
    • 6.9.8 Singapore
      • 6.9.8.1 Singapore Nebulizer market, 2014 - 2026 (USD Million)
    • 6.9.9 Philippines
      • 6.9.9.1 philippines Nebulizer market, 2014 - 2026 (USD Million)
    • 6.9.10 Indonesia
      • 6.9.10.1 Indonesia Nebulizer market, 2014 - 2026 (USD Million)
  • 6.10 Latin America
    • 6.10.1 Latin America Nebulizer market, by country, 2014 - 2026 (USD Million)
    • 6.10.2 Latin America Nebulizer market, by type, 2014 - 2026 (USD Million)
    • 6.10.3 Latin America Nebulizer market, by end use, 2014 - 2026 (USD Million)
    • 6.10.4 Brazil
      • 6.10.4.1 Brazil Nebulizer market, 2014 - 2026 (USD Million)
    • 6.10.5 Mexico
      • 6.10.5.1 Mexico Nebulizer market, 2014 - 2026 (USD Million)
  • 6.11 MEA
    • 6.11.1 MEA Nebulizer market, by country 2014 - 2026 (USD Million)
    • 6.11.2 MEA Nebulizer market, by type, 2014 - 2026 (USD Million)
    • 6.11.3 MEA Nebulizer market, by end use, 2014 - 2026 (USD Million)
    • 6.11.4 South Africa
      • 6.11.4.1 South Africa Nebulizer market, 2014 - 2026 (USD Million)

Chapter 7 Nebulizer Market - Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 7.1.1 Strategy framework analysis
  • 7.2 Company Profiles
    • 7.2.1 Koninklijke Philips N.V.
      • 7.2.1.1 Company overview
      • 7.2.1.2 Financial performance
      • 7.2.1.3 Product benchmarking
      • 7.2.1.4 Strategic initiatives
    • 7.3.1 Omron Corporation
      • 7.3.1.1 Company overview
      • 7.3.1.2 Financial performance
      • 7.3.1.3 Product benchmarking
      • 7.3.1.4 Strategic initiatives
    • 7.4.1 PARI Pharma
      • 7.4.1.1 Company overview
      • 7.4.1.2 Financial performance
      • 7.4.1.3 Product benchmarking
      • 7.4.1.4 Strategic initiatives
    • 7.5.1 Allied Healthcare Product Inc.,
      • 7.5.1.1 Company overview
      • 7.5.1.2 Financial performance
      • 7.5.1.3 Product benchmarking
      • 7.5.1.4 Strategic initiatives
    • 7.6.1 Becton, Dickinson and Company
      • 7.6.1.1 Company overview
      • 7.6.1.2 Financial performance
      • 7.6.1.3 Product benchmarking
      • 7.6.1.4 Strategic initiatives
    • 7.7.1 Agilent Technologies
      • 7.7.1.1 Company overview
      • 7.7.1.2 Financial performance
      • 7.7.1.3 Product benchmarking
      • 7.7.1.4 Strategic initiatives
    • 7.8.1 Medline Industries, Inc.
      • 7.8.1.1 Company overview
      • 7.8.1.2 Financial performance
      • 7.8.1.3 Product benchmarking
      • 7.8.1.4 Strategic initiatives
    • 7.9.1 Briggs Healthcare
      • 7.9.1.1 Company overview
      • 7.9.1.2 Financial performance
      • 7.9.1.3 Product benchmarking
      • 7.9.1.4 Strategic initiatives
    • 7.10.1 RossMax International Ltd.
      • 7.10.1.1 Company overview
      • 7.10.1.2 Financial performance
      • 7.10.1.3 Product benchmarking
      • 7.10.1.4 Strategic initiatives
    • 7.11.1 HCMed innovations Co. Ltd.
      • 7.11.1.1 Company overview
      • 7.11.1.2 Financial performance
      • 7.11.1.3 Product benchmarking
      • 7.11.1.4 Strategic initiatives
    • 7.12.1 Jiangsu Yuyue Medical Instrument Co. Ltd.
      • 7.12.1.1 Company overview
      • 7.12.1.2 Financial performance
      • 7.12.1.3 Product benchmarking
      • 7.12.1.4 Strategic initiatives
    • 7.13.1 Vectura Group Plc.
      • 7.13.1.1 Company overview
      • 7.13.1.2 Financial performance
      • 7.13.1.3 Product benchmarking
      • 7.13.1.4 Strategic initiatives
    • 7.14.1 Beurer GmBH
      • 7.14.1.1 Company overview
      • 7.14.1.2 Financial performance
      • 7.14.1.3 Product benchmarking
      • 7.14.1.4 Strategic initiatives
    • 7.15.1 Aerogen
      • 7.15.1.1 Company overview
      • 7.15.1.2 Financial performance
      • 7.15.1.3 Product benchmarking
      • 7.15.1.4 Strategic initiatives

Chapter 8 KOL Commentary

  • 8.1 KOL Views

List of Tables

  • TABLE 1 Global nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 2 Global nebulizer market, by end use, 2014 - 2026
  • TABLE 3 Global nebulizer market, by region, 2014 - 2026 (USD Million)
  • TABLE 4 North America nebulizer market, by country, 2014 - 2026 (USD Million)
  • TABLE 5 North America nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 6 North America nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 7 U.S. nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 8 U.S. nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 9 Canada nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 10 Canada nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 11 Europe nebulizer market, by country, 2014 - 2026 (USD Million)
  • TABLE 12 Europe nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 13 Europe nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 14 UK nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 15 UK nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 16 Germany nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 17 Germany nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 18 France nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 19 France nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 20 Italy nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 21 Italy nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 22 Spain nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 23 Spain nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 24 Russia nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 25 Russia nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 26 Asia Pacific nebulizer market, by Country, 2014 - 2026 (USD Million)
  • TABLE 27 Asia Pacific nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 28 Asia Pacific nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 29 Japan nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 30 Japan Nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 31 China nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 32 China nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 33 Malaysia nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 34 Malaysia nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 35 India nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 36 India nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 37 Singapore nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 38 Singapore nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 39 Indonesia nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 40 Indonesia nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 41 Philippines nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 42 Philippines nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 43 Latin America nebulizer market, by country, 2014 - 2026 (USD Million)
  • TABLE 44 Latin America nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 45 Latin America nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 46 Mexico nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 47 Mexico nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 48 Brazil nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 49 Brazil nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 50 MEA nebulizer market, by country, 2014 - 2026 (USD Million)
  • TABLE 51 MEA nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 52 MEA nebulizer market, by end use, 2014 - 2026 (USD Million)
  • TABLE 53 South Africa nebulizer market, by type, 2014 - 2026 (USD Million)
  • TABLE 54 South Africa nebulizer market, by end use, 2014 - 2026 (USD Million)

List of Figures

  • FIG. 1 Nebulizer market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Primary interviews in North America
  • FIG. 6 Primary interviews in Europe
  • FIG. 7 Primary interviews in Asia Pacific
  • FIG. 8 Primary interviews in Middle East and Africa
  • FIG. 9 Market research approaches
  • FIG. 10 Value-chain-based sizing & forecasting
  • FIG. 11 Market formulation & validation
  • FIG. 12 Commodity Flow Analysis
  • FIG. 13 Volume Price Analysis
  • FIG. 14 Market outlook (2018)
  • FIG. 15 Market trends and outlook
  • FIG. 16 Penetration & growth prospect mapping
  • FIG. 17 Market driver relevance analysis (Current & future impact)
  • FIG. 18 Treatment cost by healthcare setting (Average cost per day in USD)
  • FIG. 19 Global geriatric population, 2012 - 2020 (Million)
  • FIG. 20 Market restraint relevance analysis (Current & future impact)
  • FIG. 21 Porter's five forces analysis
  • FIG. 22 PESTLE analysis
  • FIG. 23 Respiratory diseases prevalence
  • FIG. 24 Type of nebulizers in respiratory diseases clinical trials
  • FIG. 25 Clinical trials by products
  • FIG. 26 Clinical trials by companies
  • FIG. 27 Nebulizer market: type movement analysis
  • FIG. 28 Segment dashboard
  • FIG. 29 Nebulizer market type outlook: Key takeaways
  • FIG. 30 Jet nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 31 Mesh nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 32 Ultrasonic nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 33 Nebulizer market: end use movement analysis
  • FIG. 34 Segment dashboard
  • FIG. 35 Nebulizer market end use outlook: Key takeaways
  • FIG. 36 Hospitals and clinics market, 2014 - 2026 (USD Million)
  • FIG. 37 Emergency Centers market, 2014 - 2026 (USD Million)
  • FIG. 38 Home healthcare market, 2014 - 2026 (USD Million)
  • FIG. 39 Nebulizer market: regional movement analysis
  • FIG. 40 Regional market dashboard
  • FIG. 41 Nebulizer market regional outlook: Key takeaways
  • FIG. 42 Regional marketplace: Key takeaways
  • FIG. 43 North America nebulizer market, by country, 2014 - 2026 (USD Million)
  • FIG. 44 North America nebulizer market, by type, 2014 - 2026 (USD Million)
  • FIG. 45 North America nebulizer market, by end use, 2014 - 2026 (USD Million)
  • FIG. 46 U.S. nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 47 Canada nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 48 Europe nebulizer market, by country, 2014 - 2026 (USD Million)
  • FIG. 49 Europe nebulizer market, by type, 2014 - 2026 (USD Million)
  • FIG. 50 Europe nebulizer market, by end use, 2014 - 2026 (USD Million)
  • FIG. 51 UK. nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 52 Germany nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 53 France nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 54 Italy nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 55 Spain nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 56 Russia nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 57 Asia Pacific nebulizer market, by country, 2014 - 2026 (USD Million)
  • FIG. 58 Asia Pacific nebulizer market, by type, 2014 - 2026 (USD Million)
  • FIG. 59 Asia Pacific nebulizer market, by end use, 2014 - 2026 (USD Million)
  • FIG. 60 Japan nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 61 China nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 62 India nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 63 Malaysia nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 64 Singapore nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 65 Philippines nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 66 Indonesia nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 67 Latin America nebulizer market, by country, 2014 - 2026 (USD Million)
  • FIG. 68 Latin America nebulizer market, by type, 2014 - 2026 (USD Million)
  • FIG. 69 Latin America nebulizer market, by end use, 2014 - 2026 (USD Million)
  • FIG. 70 Brazil nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 71 Mexico nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 72 MEA Nebulizer market, by country, 2014 - 2026 (USD Million)
  • FIG. 73 MEA Nebulizer market, by type, 2014 - 2026 (USD Million)
  • FIG. 74 MEA Nebulizer market, by end use, 2014 - 2026 (USD Million)
  • FIG. 75 South Africa Nebulizer market, 2014 - 2026 (USD Million)
  • FIG. 76 Strategy framework analysis
Back to Top